Literature DB >> 11531271

The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.

P Watson1, R Bützow, H T Lynch, J P Mecklin, H J Järvinen, H F Vasen, L Madlensky, P Fidalgo, I Bernstein.   

Abstract

OBJECTIVE: Hereditary nonpolyposis colorectal cancer (HNPCC) is a hereditary cancer susceptibility disorder associated with a very high risk for carcinoma of the colon and an elevated risk for certain extracolonic cancers including ovarian cancer. Our aim in this study was to describe the clinicopathologic features of ovarian cancer in HNPCC family members.
METHODS: . Members of the International Collaborative Group on HNPCC collected retrospective data on 80 ovarian cancer patients who were members of HNPCC families, including 31 known mutation carriers, 35 presumptive carriers (by colorectal/endometrial cancer status), and 14 at-risk family members.
RESULTS: Mean age at diagnosis of ovarian cancer was 42.7. Nonepithelial tumors made up only 6.4% of the cancers, and borderline tumors comprised just 4.1% of the epithelial cancers. Among frankly malignant epithelial cases, most cancers were well or moderately differentiated, and 85% were FIGO stage I or II at diagnosis. Synchronous endometrial cancer was reported in 21.5% of cases.
CONCLUSIONS: Ovarian cancer in HNPCC differs from ovarian cancer in the general population in several clinically important respects. It occurs at a markedly earlier age. It is more likely to be epithelial. If it is a frankly invasive epithelial cancer, it is more likely to be well or moderately differentiated. HNPCC patients with ovarian cancer are more likely to have a synchronous endometrial cancer than other ovarian cancer patients and are more likely to be diagnosed at an early stage. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11531271     DOI: 10.1006/gyno.2001.6279

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  50 in total

Review 1.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

Review 2.  Prophylactic surgery in Lynch syndrome.

Authors:  V Celentano; G Luglio; G Antonelli; R Tarquini; L Bucci
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

3.  Survival of patients with ovarian cancer due to a mismatch repair defect.

Authors:  Th E M Crijnen; M L G Janssen-Heijnen; H Gelderblom; J Morreau; M A Nooij; G G Kenter; H F A Vasen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 4.  Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.

Authors:  Jinru Shia; Susanne Holck; Giovanni Depetris; Joel K Greenson; David S Klimstra
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

5.  Completeness of pedigree and family cancer history for ovarian cancer patients.

Authors:  Yedong Son; Myong Cheol Lim; Sang Soo Seo; Sokbom Kang; Sang Yoon Park
Journal:  J Gynecol Oncol       Date:  2014-08-05       Impact factor: 4.401

6.  Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families.

Authors:  Kathleen Yang; Brian Allen; Peggy Conrad; C Bethan Powell; Jonathan Terdiman; Lee-may Chen
Journal:  Fam Cancer       Date:  2006-08-26       Impact factor: 2.375

7.  High risk for neoplastic transformation of endometriosis in a carrier of Lynch syndrome.

Authors:  Christine Nyiraneza; Etienne Marbaix; Mireille Smets; Christine Galant; Christine Sempoux; Karin Dahan
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

Review 8.  Basic concepts for genetic testing in common hereditary colorectal cancer syndromes.

Authors:  Kristina Markey; Lisen Axel; Dennis Ahnen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 9.  Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.

Authors:  Tuya Pal; Jenny Permuth-Wey; Ambuj Kumar; Thomas A Sellers
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.

Authors:  Sue V Petzel; Rachel Isaksson Vogel; Tracy Bensend; Anna Leininger; Peter A Argenta; Melissa A Geller
Journal:  J Genet Couns       Date:  2013-05-16       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.